Patient info

Bumetanide tablets 1 mg – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
1 mg
Contains active substance:
ATC code:
Similar medicines:

Patient leaflet - Bumetanide tablets 1 mg

1. What Bumetanide Tablets are and what they are used for

Bumetanide Tablets 1 mg contain the active substance bumetanide. Bumetanide is one of a group of medicines called diuretics (water tablets). They make the kidneys remove water from the body. Bumetanide Tablets are used to treat oedema, which is a build-up of fluid in the body. This may occur in many situations, for instance, with liver and kidney problems, or with heart failure (when the heart doesn’t pump efficiently).

2. What you need to know before you take Bumetanide Tablets

DO NOT take Bumetanide Tablets:

  • If you are allergic to bumetanide, sulfonylureas or any of the other ingredients of Bumetanide Tablets (listed in section 6).
  • If you have severe progressing kidney disease, especially if you are excreting a very low amount of urine or if you cannot excrete any urine at all.
  • If you have serious problems with your liver.
  • If you have been told that you have low levels of certain chemicals (electrolytes) in your blood. Warnings and precautions

Talk to your doctor or pharmacist before taking Bumetanide Tablets:

  • If you are on a low-salt diet or have been told you have an imbalance of body chemicals (electrolytes). Bumetanide can cause disturbances of these body chemicals and your doctor may want to monitor your blood and urine, particularly if you have muscle cramps, numbness, headache, feel faint, weak, dizzy or sick. If you are elderly your doctor may reduce your dose. ■ If you are a diabetic or if you have ever had diabetes your doctor may ask for periodic checks on urine and blood glucose.
  • If you suffer from any kidney disease, or are taking any drugs that may affect the kidneys, your doctor may closely monitor your body fluids and kidney functions.
  • If you suffer from low blood pressure or are taking other medicines to treat high blood pressure. ■ If you are elderly and taking high doses of Bumetanide.
  • If you have ever developed a severe skin rash or skin peeling, blistering and/or mouth sores after taking Bumetanide Tablets or other sulphonamides, e.g., Loop diuretics. ■ If you have problems with your liver.

Tell your doctor if any of these apply to you. He/she may want to monitor you or do some tests. Serious skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported in association with Bumetanide Tablets treatment. Stop using Bumetanide Tablets and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.

Children

Do not give this medicine to children under 12 years of age because limited information is available and it is not known if it is safe to use.

Other medicines and Bumetanide Tablets

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription, for example, herbal remedies and health supplements from a pharmacy, supermarket or health food shop, as this medicine may interact with other drugs.

The effects of these medicines may change, so the dose may need adjustment when given in conjunction with these drugs, especially if you are taking:

  • medicines to treat heart failure or irregular heartbeats (cardiac glycosides, e.g. digoxin and digitalis, amiodarone, disopyramide, flecainide, sotalol)
  • other medicines used to treat high blood pressure (e.g. methyldopa and captopril, acetazolamide)
  • other medicines that may lead to loss of potassium, e.g.:

    ❑ medicines used to treat depression (reboxetine)

    ❑ medicines used in asthma (theophylline)

    ❑ medicines used to treat infection (amphotericin)

    ❑ corticosteroids

  • Bumetanide may potentiate the effect of blood pressure lowering drugs and drugs inducing a fall in blood pressure on standing up
  • medicines used to treat anxiety and insomnia (diazepam)
  • medicines used to treat diabetes (e.g. sulfonylyureas)
  • analgesics (non-steroidal anti-inflammatory drugs e.g. naproxen and ibuprofen) ■ any medicines that may have a harmful effect on your kidneys or your hearing such as antibiotics called aminoglycosides (e.g. gentamycin and neomycin and cephalosporins) ■ medicines used to treat psychosis (amisulpride, sertindole, atomoxetine, pimozide) ■ Lithium – used for mental illnesses. To help stop side effects your doctor may need to change the dose of your lithium and check the amount of lithium in your blood

Bumetanide Tablets with food and drink

Bumetanide Tablets can be taken with or without food and drink.

Pregnancy, breast-feeding and fertility

Do not take Bumetanide Tablets if you are pregnant (or think you may be), are planning to become pregnant or are breast-feeding, unless your doctor has decided that it is absolutely necessary. Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

This medicine may cause dizziness, drowsiness, tiredness or feeling faint as side effects. You must not drive or use machines if you get any of these side effects.

Bumetanide Tablets contain lactose.

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

Bumetanide Tablets contain less than 1 mmol sodium (23mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Bumetanide Tablets

Always take Bumetanide Tablets exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Your doctor will decide the best dose for you and may change it depending on how you respond to treatment

The tablets should be taken by mouth.

The tablets can be divided into equal doses.

Adults

The usual recommended dose is 1mg (one tablet) which can be taken as a single morning or as an early evening dose. Depending on your response to single tablet dose, your doctor may decide to prescribe you a higher dose.

Elderly patients

The dosage will be adjusted according to response. A dose of 0.5mg (half a 1mg tablet) may be sufficient in some elderly patients.

Children

Do not give Bumetanide Tablets to children under 12 years of age.

Package leaflet: Information for the user

Bumetanide Tablets 1mg

Bumetanide

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. ■ If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. If you take more Bumetanide Tablets than you should

If you think that you, or any other person, have taken too many tablets, contact your doctor or hospital casualty department immediately. Take any remaining tablets and this leaflet with you so that the medical staff know exactly what you have taken.

If you forget to take your Bumetanide Tablets

If you forget to take your medicine and you are less than 12 hours late, you can still take it. If you are more than 12 hours late taking your medicine then leave out this dose. Take the next dose at the usual time. Do not take a double dose to make up for a forgotten tablet. If you keep forgetting to take your tablets, speak to your doctor.

If you stop taking Bumetanide Tablets:

Keep taking Bumetanide Tablets, even if you feel well. Do not stop taking Bumetanide Tablets unless your doctor tells you to.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop taking bumetanide and seek medical help immediately if you have any of the following symptoms. You may be having a severe allergic reaction.

  • Difficulty breathing, swelling of the face, lips, tongue or throat
  • Severe itching of the skin with a red rash or raised lumps
  • Reddish non-elevated, target-like or circular patches on the trunk, often with central blisters, skin peeling, ulcers of mouth, throat, nose, genitals and eyes. These serious skin rashes can be preceded by fever and flu-like symptoms [Stevens-Johnson syndrome, toxic epidermal necrolysis] Tell your doctor immediately if you notice any of the following side effects, as they may indicate a reduction in bodily fluid and electrolytes (chemicals in the blood) and can be serious: ■ muscle cramps, numbness or twitching
  • feeling faint, dizzy or sick
  • tiredness and confusion
  • thirst
  • fever or chills
  • brain disease that may be marked by headache, fits or coma
  • you feel shaky, trembly or faint and your heart starts to beat fast or irregularly Your doctor may need to test your blood or urine before deciding whether you can continue with your medicine.

Other side effects

  • abdominal pain, indigestion, vomiting, nausea, diarrhoea and stomach cramps ■ pain and swelling in joints, muscles, bones
  • low blood pressure or fall in blood pressure on standing up which may cause light-headedness or fainting
  • tingling / pins and needles feeling (usually in the hands and feet)
  • blood disorders (which may be indicated by bruising, nose bleeds, bleeding easily, sore throat or infections)
  • skin rashes and itching
  • feeling of ‘spinning’(vertigo)
  • you may also experience hearing disturbances such as ringing and sense of fullness of ears and deafness
  • jaundice caused by increased bilirubin in blood (a substance produced in the liver) which can make skin and whites of eyes appear yellow
  • enlargement of breasts (in men)
  • painful breasts
  • kidney failure
  • Changes in blood test results due to effects on blood cells, salts and other chemicals in the body (for example changes in levels of creatinine, potassium, sodium, magnesium, calcium, chloride, uric acid, blood glucose levels, lipid/cholesterol). These may be found during routine blood tests. Your doctor can explain this more.

Reporting side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Bumetanide Tablets

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.

Do not store above 25°C.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Bumetanide Tablets contain:

The active substance is bumetanide.

The other ingredients are microcrystalline cellulose (E460(i)), lactose monohydrate, magnesium stearate (E572), maize starch and sodium lauryl sulfate.

What Bumetanide Tablets look like and contents of the pack:

Bumetanide Tablets 1 mg are white and plain on one side and have a breakline on the other side, with ‘1’ above the breakline and ‘BMT’ below the breakline.

They are packed in blister strips and supplied in cartons of 20, 28, 30, 56, 60, 84 and 120 tablets. Not all pack sizes are marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder: Niche Generics Limited, 1 The Cam Centre, Wilbury Way, Hitchin, Hertfordshire, SG4 0TW, United Kingdom

Manufacturer: Niche Generics Ltd, Unit 1, Waterloo Farm Courtyard, Stotfold Road, Arlesey, SG15 6XP, United Kingdom

This leaflet was last revised in: November 2024

Title: Bumetanide 1mg Niche UK

MA Number/s: UK: PL 19611/0003

Date of Origination: 04/12/2002

Dimensions: 300mm x 270mm

Colours: Black

Version Number: 16

Revision Date: 13/11/2024

Reason for Revision: Updated to include PRAC

recommendations, Sodium content information and details of National Reporting System.

Section 2 updated to add skin reaction warnings.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 19611/0003

Last revision stated in the text: 13 November 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Bumetanide tablets 1 mg

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Bumetanide
Strength 1 mg
Pharmaceutical form Oral tablet
White to off-white, round, normal convex, uncoated tablet of approximately 6 mm, plain on one side with a breakline and ‘1’ centrally above ‘BMT’ on the other side.
The tablet can be divided into equal doses.
How is it taken Oral
Excipients Microcrystalline cellulose, Lactose monohydrate, Magnesium stearate, Maize starch, Sodium lauryl sulfate
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life AL/AL 39months
AL/PVC/PVdC 48 months
Storage Do not store above 25°C.
Drug group (ATC) Diuretics, high-ceiling diuretics, sulfonamides, plain
  1. C Cardiovascular system drugs
    1. C03 Diuretics
      1. C03C High-ceiling diuretics
        1. C03CA Sulfonamides, high-ceiling diuretics, plain
          1. C03CA02 bumetanide
Marketing authorisation PL 19611/0003 (first authorised 6 July 1999)
Marketing authorisation holder Niche Generics Limited
Codes GTIN 5060020121067 · BNF 02020200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.